INFLUENZA A VIRUS - ANVISA Registration 80213250117

Access comprehensive regulatory information for INFLUENZA A VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80213250117 and manufactured by R-BIOPHARM AG. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until Nov 04, 2025.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including NOVATEC IMMUNDIAGNOSTICA GMBH TECHNOLOGIE & WALDPARK, CERTEST BIOTEC, S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80213250117
2 Related Devices
Registration Details
ANVISA Registration Number: 80213250117
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

RIDASCREEN INFLUENZA A IgA
Risk Class III

Registration Details

80213250117

25351240932200557

64128853000196

Company Information

R-BIOPHARM AG
Germany
PT: ALEMANHA

Dates and Status

Nov 04, 2005

04/11/2025

09/18/2025 19:00:01

RIDASCREEN INFLUENZA A IgA
Risk Class III

Registration Details

80213250117

25351240932200557

64128853000196

Dates and Status

Nov 04, 2005

04/11/2025

09/18/2025 19:00:01